Showing 15 posts of 737 posts found.

GSK takes Egyptian lead

October 16, 2008
Sales and Marketing Egypt, GSK, em

GlaxoSmithKline has extended its reach into emerging markets by acquiring Bristol-Myers Squibb’s Egyptian mature products business for £125 millionThe move …

GSK’s pricing deal for Tyverb fails to sway NICE

October 15, 2008
Sales and Marketing GSK, NICE, breast cancer

NICE has spurned GSK's risk-sharing proposal for its breast cancer treatment Tyverb, saying the drug is still too expensive to …

GSK plans research job losses in UK

October 3, 2008
Research and Development GSK, restructure

GlaxoSmithKline is set to cut about 850 jobs in early-stage research and development at sites across the world, including the …

GSK seeks risk-sharing deal for Tyverb

September 17, 2008
Sales and Marketing Cancer, GSK, NICE, par

GlaxoSmithKline has approached the government for a new pricing deal on its breast cancer drug Tyverb, which could make it …


GSK unveils new cancer unit

September 17, 2008
Research and Development Cancer, GSK

 GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …

Viehbacher leaves GSK for Sanofi

September 10, 2008
Sales and Marketing GSK, Sanofi

Chris Viehbacher is set to leave GlaxoSmithKline for a lead role at Sanofi-Aventis after last year losing out to Andrew …

GSK signs $1.5 billion insomnia collaboration

July 16, 2008
Sales and Marketing Actelion, GSK, insomnia

 GlaxoSmithKline has joined forces with Swiss biopharmaceutical company Actelion to bring a new insomnia treatment to market.The deal could be …

Stout to quit as GSK restructures

December 10, 2007
Sales and Marketing GSK, restructure

GlaxoSmithKline has unveiled new appointments to its board of directors and the departure of its current president of Pharmaceuticals David …

Avandia safety scare costs GSK $200m

July 26, 2007
Sales and Marketing GSK

GlaxoSmithKline saw its performance in the second quarter of this year badly affected by a 22% slump in sales of …

GlaxoSmithKline plans five launches for 2007

February 9, 2007
Sales and Marketing GSK

GlaxoSmithKline is planning to launch five new products in 2007, bringing to an end a long period for the company …

Packer Forbes scoops GSK Tycerb account

January 26, 2007
Medical Communications GSK, Packer Forbest

London-based agency Packer Forbes Communications has won its first breast cancer account, to promote GlaxoSmithKline's potential blockbuster, Tycerb.The agency beat …

GSK gambles on success of new European pricing deal

September 25, 2006
Sales and Marketing EU, GSK

GlaxoSmithKline has unveiled a new deal which could break the deadlock over the pricing of medicines in Europe.The groundbreaking agreement …

R&D Scoreboard poor gauge of pharma investment in the UK

November 8, 2005
Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard

 The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …

GSK makes strategic biotech acquisition

May 6, 2005
Research and Development, Sales and Marketing GSK, biotech

 GlaxoSmithKline will acquire a Seattle-based biotech that manufactures a key component in many of the candidates in its vaccine pipeline, …

Latest content